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Abstract
Background
Both brain structural abnormalities and neurocognitive impairments are core features of
schizophrenia. We have previously reported enlargements in subcortical brain structure vol-
umes and impairment of neurocognitive functioning as measured by the MATRICS Cogni-
tive Consensus Battery (MCCB) in early onset schizophrenia spectrum disorders (EOS). To
our knowledge, no previous study has investigated whether neurocognitive performance
and volumetric abnormalities in subcortical brain structures are related in EOS.
Methods
Twenty-four patients with EOS and 33 healthy controls (HC) were included in the study.
Relationships between the caudate nucleus, the lateral and fourth ventricles volumes and
neurocognitive performance were investigated with multivariate linear regression analyses.
Intracranial volume, age, antipsychotic medication and IQ were included as independent
predictor-variables.
Results
The caudate volume was negatively correlated with verbal learning performance uniquely in
the EOS group (r=-.454, p = .034). There were comparable positive correlations between
the lateral ventricular volume and the processing speed, attention and reasoning and prob-
lem solving domains for both the EOS patients and the healthy controls. Antipsychotic medi-
cation was related to ventricular enlargements, but did not affect the brain structure-function
relationship.
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Conclusion
Enlargement of the caudate volume was related to poorer verbal learning performance in
patients with EOS. Despite a 32% enlargement of the lateral ventricles in the EOS group,
associations to processing speed, attention and reasoning and problem solving were similar
for both the EOS and the HC groups.
Introduction
Schizophrenia is a disorder of the brain in which structural abnormalities and impairment of
neurocognitive function are features that may reflect underlying neurodevelopmental pathol-
ogy [1–4]. Neurocognitive functioning is usually considered in relation to neocortical structure
and function, but subcortical brain structures are also implicated in cognitive processing
through multiple cortico-striatal loops [5–9]. Studies of patients with adult onset schizophrenia
have reported relationships between the size of specific subcortical brain structure volumes and
the severity of cognitive dysfunctions [10–13].
Approximately 5% of schizophrenia patients have EOS, i.e. illness onset before the age of 18
[14]. Current evidence shows a continuity between EOS and adult onset schizophrenia, with
phenomenological, cognitive, genetic and neuroimaging data pointing toward similar neurobi-
ological correlates and clinical deficits [15, 16]. To date, most studies conclude that EOS consti-
tutes a more severe presentation of the disorder, with a worse long-term outcome [17, 18].
More optimistically, recent reports conclude that better symptomatic and functional outcomes
were recorded for EOS patients compared to adult onset schizophrenia when detected early
and given specialized treatment [19].
Both brain structural and neurocognitive abnormalities are reported in EOS [20–25]. In a
previous study, we investigated 27 subcortical brain structure volumes in patients in the narrow
EOS spectrum (not including psychotic disorder NOS), and reported an enlargement of the
caudate nucleus, the lateral and the fourth ventricles volumes compared to the healthy control
(HC) group [22]. Antipsychotic medication was related to lateral ventricle enlargements, and
most likely the bilateral enlargements of caudate volumes. Furthermore, impairment in the six
neurocognitive domains of the MATRICS Cognitive Consensus Battery (MCCB)[26, 27] has
previously been reported [23, 28].
Investigating the relationship between brain structure volume and neurocognitive function
may provide insights into the neurodevelopmental underpinnings of schizophrenia [29]. In a
review of adult onset schizophrenia, it was concluded that there is strong evidence to suggest
that progressive changes occur early in the course of the illness [30]. In this context, studies of
patients with EOS provide an opportunity to explore putative brain pathology free from the
potential confounding effects of long-term medication, age-related neurodegeneration and sev-
eral of the suggested disease risk-related environmental factors [31, 32].
The caudate nucleus is part of the basal ganglia, which receive widespread input from the
cerebral cortex and the thalamus, and projections are returned through output in thalamocorti-
cal pathways [33] and contribute to a wide range of cognitive functions, including learning,
memory, executive functions and the processing of rewards and other feedback [9, 34]. The
basal ganglia are characterized by prominent dopaminergic pathways and represent major
locations of synaptic plasticity [35–37]. The dopamine hypothesis has been central in schizo-
phrenia research since the 1950s, and contemporary pathophysiological models assume that
psychosis is triggered by dysregulation of dopaminergic activity in the brain [38, 39].
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The ventricular system contains cerebrospinal fluid that has a number of important func-
tions, including cushioning and protection of the brain, removal of waste material and trans-
port of hormones and other substances [40]. The most consistently reported brain structure
abnormality in schizophrenia is enlarged ventricles, which is found in 80% of the studies in
adult onset schizophrenia [2, 41]. However, the role of the increased ventricular system in
schizophrenia is still largely unknown. Substantial evidence relates both the caudate and the
lateral ventricles enlargements to exposure to antipsychotic medication, including both first
and second generation compounds [22, 42–45]; however, some studies have not found rela-
tionships for second-generation antipsychotics [46].
The aim of the current study was to test whether there was a relationship between neurocog-
nitive performance measured by the MCCB and the brain structure volumes (caudate nucleus
and the lateral and fourth ventricles) found to be enlarged in our previous study of the same
EOS patients [22]. Putative effects of antipsychotic medication to any relationships between
brain structure and cognition were investigated.
Materials and Methods
Subjects
The patients were participants in a broader research project on early onset psychosis conducted
at the University of Oslo, Norway [24, 25, 28]. Inclusion criteria were age of illness onset below
18 years a diagnosis within the broader schizophrenia spectrum (schizophrenia or schizoaffec-
tive disorder or psychotic disorder not otherwise specified (NOS)), in order represents the
larger schizophrenia spectrum disorders. This is a difference from the patient population in
our previous study where patients with psychosis NOS (n = 6) were excluded [22]. In the cur-
rent study, 24 out of a total of 28 scanned patients were used for further analyses. F our subjects
were excluded due to poor image quality related to movement or dental braces in four subjects.
The HC group consisted of 33 research participants recruited through letters to a group of ran-
domly selected individuals from the Norwegian population, as well as through advertisements
in four schools in the greater Oslo area. All the controls attended regular school at normal
grade levels, and the group was screened for mental problems using The Mini-International
Neuropsychiatric Interview (M.I.N.I.) screening module [47]. A positive response to any of the
questions was grounds for exclusion from the study. Clinical and demographic data are pre-
sented in Table 1.
General exclusion criteria were any known brain injury or neurological disease, along with
standard contraindications for MRI (metal in the body or cardiac pacemaker) and an IQ<70. A
clinical neuroradiology specialist evaluated all of the image series for organic brain pathology.
Written informed consent was obtained from both patients and controls, as well as from
their parents if the adolescent was younger than 16 years of age. According to the Norwegian
Health Laws, minors between 16 to 18 years of age can consult and consent to medical treat-
ment independently of parental approval. The capacity for the patients to consent to the study
was determined by their primary physicians, their parents and by our project group. Both con-
sent forms and procedures for the study were approved by the local Regional Committee for
Medical Research Ethics and the Norwegian Data Inspectorate.
Clinical assessment
As described previously [28, 48], diagnostics were carried out using the Structural Clinical
Instrument of Diagnosis for DSM-IV Axis I disorders (SCID-I), modules A-D. All of the inter-
viewers were clinical psychologists who had participated in a training course in SCID assess-
ment based on a training program for this purpose. The mean overall kappa for the SCID was
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0.77. Psychiatric symptoms and level of functioning were assessed using the Positive and Nega-
tive Syndrome Scale (PANSS)[49] and the Global Assessment of Functioning–Split Version
(Split-GAF)[50]. An estimated duration of untreated psychosis (DUP) was defined as the num-
ber of weeks between the first time any positive symptom on the PANSS reached four points
and the first time the patients received psychiatric treatment (with or without antipsychotic
medication) such as psycho-education and cognitive therapy. To help obtain a reliable measure
of DUP, information from interviews with the patients, parents, treating clinicians and journal
data were collected and thoroughly discussed within the research group (AH, MJL and RT) for
each patient. Table 1 summarizes the clinical and demographic data in both the patient and
HC groups.
Neurocognitive assessments
Clinical psychologists trained in neurocognitive testing assessed all research participants using
the complete MCCB battery. The present study included the following domains [26]: 1) Speed
of processing, 2) Attention, 3) Working Memory, 4) Verbal Learning, 5) Visual Learning, and
6) Reasoning and Problem Solving. The seventh domain, Social Cognition, was excluded since
we previously found that this test was not sensitive to social cognitive impairments within this
group [23]. Four missing test results were replaced by the mean value on the specific test for
the EOS group, and the calculation of the IQ estimate was based on the four sub-tests of the
Wechsler Abbreviated Scale of Intelligence (Vocabulary, Similarities, Block Design and Matrix
Reasoning)[51].
Table 1. Clinical and demographic data for the EOS patients and HC.
EOS (n = 24) Mean (SD) HC (n = 33) Mean (SD) Test statistics
Number of females (%) 12 (50) 17 (52) n.s.
Right hand dominance (%) 20 (83) 30 (91) n.s.
Age at scan (years) 16.1 (1.9) 15.8 (1.8) n.s.
Mother’s education (years)a 13.6 (2.6) 15.5 (2.8) t(54) = -2.484, p = .016*
Father’s education (years)b 14.1 (2.8) 14.4. (3.1) n.s.
Full-scale IQ (WASI) 96.8 (16.3) 107.3 (14.6) t(55) = -2.524, p = .015*
Schizophrenia (n/%) 15 (62.5)
Schizoaffective (n/%) 3 (12.5)
Psychosis NOS (n/%) 6 (25)
Age at onset of disorder (years) 14.5 (2.0)
Duration of illness (years) 1.5 (1.0)
GAF—function 47.8 (15.4)
GAF—symptom 49.9 (14.0)
PANSS—positive 14.3 (4.3)
PANSS—negative 12.3 (5.7)
PANSS—general 29.7 (7.5)
PANSS—total 57.3 (13.4)
DDD (n = 17/71%) 1.1 (0.7)
Duration of antipsychotic medication (days) n = 16 168.6 (160) range 19–707
DUP (weeks) 33 (44.6) range 1–208
a n = 22 for the patient group
b n = 21 for the patient group
* p<.05
doi:10.1371/journal.pone.0130435.t001
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Antipsychotic medication
Seventeen patients (71%) received antipsychotic medication, while seven patients did not
receive any antipsychotic medication. All of the medicated patients received second-generation
antipsychotic medication (Aripiprazole, Olanzapine, Quetiapine, Risperidone or Ziprazidone),
while two patients (8%) received a combination of first- (Chlorprothixene or Haloperidol) and
second-generation antipsychotic medication. For the purpose of statistical analysis, the dosages
were converted to defined daily dose (DDD) (http://www.whocc.no/ddd/definition_and_
general_considera/). The duration of antipsychotic medication is reported in days given in
Table 1.
MRI acquisition
All images were acquired using a 1.5 Tesla Siemens Sonata scanner (Siemens Medical Systems,
Erlangen, Germany), and also included two high-resolution 3D Spoiled Gradient Recalled
(3D-SPGR) T1-weighted image series, with the following acquisition parameters applied: 124
contiguous 1 mm sagittal slices, flip angle = 35°, repetition time (TR) = 24 ms, echo time (TE)
= 6.0 ms, field of view (FOV) = 256 mm, acquisition matrix = 256 × 256, yielding an isotropic
voxel size of 1 mm3. In addition, a whole-brain, dual-echo (for varying image contrast) coronal
T2 turbo spin-echo sequence (TR = 8000 ms, TE1 = 11 ms, TE2 = 89 ms), 128 slices, slice thick-
ness 2 mm, FOV = 256 mm, acquisition matrix = 256 × 214, was acquired for each patient. All
patients and controls were examined during the same study period, and there was no scanner
upgrade during this time.
Image segmentation
All image segmentation was performed using the automatic brain segmentation software tool
FreeSurfer version 4.0.4. The two T1-weighted images were averaged and rigid-body registered
to each other in order to increase the signal-to-noise ratio. Subcortical volumes were estimated
from the fully automated procedure for volumetric estimations of subcortical brain structures
implemented in FreeSurfer, which has previously been shown to be comparable in accuracy to
manual labeling [52]. Based on our previous findings, the caudate nucleus, the lateral ventricle
and the fourth ventricle volumes were selected for the study.
Measurements of ICV were performed with a semi-automated procedure using the software
tool Brain Voyager QX (Brain Innovation, Maastricht, the Netherlands). The dual-echo PD/
T2-weighted image series was iso-voxelated and co-registered to the T1-weighted image series
using sinc interpolation, so that all image series were accessible as overlays for the correct
determination of the ICV. Semi-automated segmentation was performed by primarily using
the proton density-weighted image series. The T1/T2-weighted image series was consulted
whenever there was doubt as to which tissue class a voxel belonged to, and in order to measure
reliability, five randomly selected subjects were chosen for the re-measuring of their ICV vol-
umes. The same rater performed this procedure, and the intra-rater reliability correlation was
0.99.
Statistical analyses
Data analyses were performed with IBM SPSS Statistics, version 20. For the demographics,
two-tailed students t-tests were used for group comparisons of continuous variables and chi-
squares for the group comparisons of categorical data.
Both brain volumes and MCCB domain scores were normally distributed. The brain struc-
tures volumes were investigated for covariance using partial correlation analysis.
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The brain volumes were investigated for hemispheric laterality for both volumes and struc-
ture-function relationships. Because there were no differences between left and right side vol-
umes and volume-function relationship, right and left side were collated in order to reduce the
number of statistical tests.
Group differences in performance on the MCCB domains were investigated using two-way
t-tests and the raw scores. Group differences for total lateral ventricular, fourth ventricle and
caudate nucleus were analyzed using analysis of covariance (ANCOVA) with ICV and age as
covariates.
The results were considered significant at p<0.05.
Brain structure—neurocognitive function relationships. In order to investigate associa-
tions between the brain structure volumes and the MCCB performance, we performed six mul-
tivariate linear regression analyses (separated for patients and controls) with each of the
structure volumes as the dependent variables and the neuropsychological scores, plus the possi-
ble confounders (ICV, age at scan, IQ and antipsychotic medication) as independent-predictor
variables. For any significant structure-function correlations, Fisher’s r-to-z transformations
were computed. To determine whether there were between-group differences in the correlation
coefficients, the z-scores were tested using t-tests (at http://vassarstats.net/rdiff.html).
Relationships between brain structure volumes and MCCB scores with psychiatric symptom
and function ratings (the PANSS subscores and the split-GAF scores) as well as DUP, total
duration of antipsychotic medication (total number of days) and DDD were investigated for all
patients (added as independent predictor-variables) in separate linear regression analyses with
each of the brain structure volumes as dependent variables.
In order to investigate the potential influence of diagnosis, the patient group was divided
into one schizophrenia group (schizophrenia and schizoaffective disorders; n = 18) and a psy-
chosis NOS group (n = 6). The brain volumes, the MCCB domains and any relevant brain vol-
ume/MCCB domain relationship were compared between the two patient groups.
All test results were considered significant at p<.05.
Results
Clinical and demographic variables
Table 1 presents demographic and clinical variables. The HC had a significantly higher current
full-scale IQ and more years of mothers’ education than the patients. There were no group dif-
ferences in age, gender, fathers’ education or handedness.
Brain structure volumes and the MCCB domains
Table 2 presents the results for the group comparisons of the brain structure volumes and the
MCCB domains, respectively. There were significant group differences on all measures.
There were trend-level negative correlations between the PANSS total score, and the Verbal
Learning domain (r = -.421, p = .051) and the Processing Speed domain (r = -.402, p = .064).
No significant differences were found in any of the three brain structure volumes between
the patients with a diagnosis of schizophrenia or schizoaffective (n = 18) versus psychosis NOS
(n = 6) using ANCOVA.
Associations between the brain structure volumes and the MCCB
domains
Table 3 presents the correlation coefficients between each of the three brain structure volumes
and the MCCB domain scores, after corrections for possible confounders.
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There were no structure-function differences between the more narrow schizophrenia sub-
group (n = 18) and the patients with psychosis NOS (n = 6).
The structure-function correlations remained unchanged when the PANSS subscale scores
and the split-GAF scores were added to the group of confounders in separate analyses for each
brain structure volume. There was a significant relationship between the GAF symptom mea-
sure and the volume of the lateral ventricles (r = -.437, p = .029).
Fig 1 presents the relationships between the caudate volume and the verbal learning domain
in EOS and the HC.
Table 2. Group comparisons of the brain structure volumes and the MCCB domains.
EOS HC
Brain Volume Estimated Marginal Means Standard Error Estimated Marginal Means Standard Error F p
Caudate 8,421 148 7,799 127 10.57 .002**
Lateral ventricles 14,738 1,140 11,151 971 5.718 .020*
Fourth ventricle 1,986 92 1,726 78 4.600 .037*
Neurocognitive Domain Mean (raw scores) S.D. Mean (raw scores) S.D t (df = 55) P
Processing Speed 40.5 8.1 49.1 8.6 -3.816 .000**
Attention 1.7 0.6 2.2 0.6 -2.664 .010**
Working Memory 13.3 2.4 17.2 2.9 -5.408 .000**
Verbal Learning 23.3 5.7 29.2 3.6 -4.848 .000**
Visual Learning 24.4 8.1 28.6 4.3 -2.503 .015*
Reasoning and Problem Solving 17.8 5.6 21.9 4.5 -3.062 .003**
* p<.05
** p<.01
doi:10.1371/journal.pone.0130435.t002
Table 3. Linear regression relationships between brain structure volumes and the MCCB domain scores.
Lateral Ventricles Fourth
Ventricle
Caudate Fisher’s z-test
EOS HC EOS HC EOS HC
Processing Speed Correlation .451 .487 -.145 .103 .179 .161 n.s.
Signiﬁcance .014* .002* .249 .284 .201 .186
Attention Correlation .530 .480 .041 .147 .294 -.002
Signiﬁcance .004* .002* .424 .207 .082 .495 n.s.
Working Memory Correlation .317 .327 .128 .121 .017 .082
Signiﬁcance .066 .032 .275 .251 .468 .325
Verbal Learning Correlation -.132 .300 -.179 .160 -.462 .149 z = -2.28
Signiﬁcance .269 .045 .201 .186 .012* .203 .023*
Visual Learning Correlation .192 -.004 .266 .038 .138 -.112
Signiﬁcance .184 .491 .105 .416 .260 .268
Reasoning and Problem Solving Correlation .413 .367 .064 .254 .057 .342 n.s.
Signiﬁcance .023* .018* .383 .077 .396 .026*
* p<.05
doi:10.1371/journal.pone.0130435.t003
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Relationships to medication and symptom scores
There was a significant positive correlation between the lateral ventricle volume and DDD of
antipsychotic medication (r = .366, p = .039). There were no relationships to duration of anti-
psychotic treatment or DUP for any brain structure volume.
There were no statistical relationships between the PANSS and Split-GAF scores and the
brain structure volumes, with the exception of a negative correlation between the lateral ventri-
cle volume and the GAF symptom score (r = -.437, p = .029), i.e.. larger ventricle volumes
related to more symptoms.
Additional analyses
Despite increases in both the caudate (5% increase) and the lateral ventricle (25% increase) vol-
umes in medicated patients compared to non-medicated patients, the group differences were
not statistically significant.
There were no statistical group differences between medicated and non-medicated patients
on the Verbal Learning domain (mean score 22.9 (SD = 5.9) versus 24.1 (SD = 5.6)) for the
unmedicated patients.
The correlation coefficients for the caudate volume and verbal learning relationships were
not statistically different between the medicated and the non-medicated patient groups.
Discussion
The main finding in this study was a negative correlation between the caudate volume and the
verbal learning performance in the EOS group, i.e. larger caudate volumes were related to
poorer verbal learning performance. This relationship was significantly different from that in
the HC. A second finding was that correlations between the lateral ventricular volume and pro-
cessing speed, attention and reasoning and problem solving were similar in EOS and HC.
Fig 1. Relationship between the caudate volume and the verbal learning domain in EOS and the HC.
doi:10.1371/journal.pone.0130435.g001
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There was also a significant correlation between the caudate volume and the reasoning and
problem solving domain for the HC, however the relationship between these measures was not
statistically different from the relationship between these measures for the EOS group.
The findings show relationships between cognitive functions and the caudate volume. How-
ever, most of the neurocognitive measures were unrelated to the caudate volume. This could
mean that the enlargement as such does not predict neurocognitive deficits in EOS, or it may
also indicate that total caudate volume is not a sensitive measure for an investigation of rela-
tionships to neurocognitive functioning. However, two studies of healthy subjects have
reported that caudate volume is related to neurocognitive function. For boys aged 4–18, a posi-
tive correlation between IQ and left striatal volumes (adjusted for total brain volume) has been
reported [53]. The second study found a negative correlation between gray matter density in
the caudate and full-scale IQ regardless of gender [54]. In accordance with these findings, the
present study demonstrates a positive relationship between the caudate volume and the reason-
ing and problem solving domain for the HC group. Taken together, the results indicate that
caudate volume is important for normal cognitive functioning. In the current study there was a
positive relationship between the caudate volume and the reasoning and problem solving
domain for the HC group, indicating that the volume of this structure may relate to cognitive
processing efficiency for executive functions. While studies of lesions and direct electrical stim-
ulation of the head of the caudate have found this structure to be involved in various language
functions and semantic processing [55, 56], a recent study on the neural basis of language pro-
cessing suggests that it is probable that direct electrical stimulation interrupts a more general
striato-cortical executive “amodal” loop controlling language and other cognitive functions
[57].
There was a non-significant trend relationship between verbal learning and PANSS total
scores, suggesting a relationship between illness severity and verbal impairment. Verbal learn-
ing was the most severely affected domain in our baseline study on an overlapping subject sam-
ple, with a mean standard deviation of -1.8 compared to the HC [58]. Interestingly, verbal
learning and memory have been found to be the most consistently and significantly affected
domains in EOS [21]. However, symptom assessment intertwines with antipsychotic medica-
tion, as the more severely ill patients may receive more medication, which in turn can result in
lower symptom scores. Therefore, analysis of the relationships between antipsychotic medica-
tion effects, brain structure, neurocognitive functioning and psychiatric symptoms is compli-
cated and unique effects are difficult to investigate. Antipsychotic medication is effective for
the treatment of positive symptoms in EOS, but has only a small effect on negative symptoms
and neurocognitive functioning [59, 60].
In contrast to a significant amount of research and findings for the understanding of neuro-
developmental trajectories in cortical brain volumes [61], few studies have investigated rela-
tionships between subcortical brain structure volumes and neurocognitive function in
schizophrenia. To the best of our knowledge, there is no such study in EOS. Some studies of
adult schizophrenia have failed to find any relationship between subcortical brain structure
measures and neurocognitive functioning [62, 63]. However, others have found relationships
between putamen and verbal learning, executive and working memory performance [64],
between caudate and putamen volumes, with attention and vigilance [65] and between caudate
and working memory [66].
More recent studies indicate that shape and not size is a more sensitive measure of the asso-
ciation between neuroanatomical brain structures and neurocognitive performance. In a study
of preadolescent children, an expanded shape of the putamen and caudate nucleus was related
to poorer performance on tests of neurocognitive function, but not with regard to volume [67].
Basal ganglia regional shapes also correlate with fluid intelligence (abstract reasoning and rule
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extraction abilities) and spatial intelligence (the spatial manipulation of working memory) of
the right striatal structures (the caudate, putamen and nucleus accumbens), but not crystallized
intelligence (verbal and numerical reasoning) in adults [68]. In a study of shape measures
(local width and local deformation) of the caudate and the hippocampus in patients with adult
onset schizophrenia, there were shape deformities in patients compared to the HC [69]. The
study had a longitudinal design, and reported no shape changes between 3 to 12 months of
treatment with antipsychotic medications.
Another methodological refinement could be to distinguish between, e.g. the ventral-and
dorsal caudate regions, involved in learning and response executions respectively [68]. A recent
meta-analytic review of fMRI studies presented a comprehensive “topographical map” of how
body and eye movements, cognitive functions, emotional and reward processes and somato-
sensory functions are been regionally represented within the basal ganglia [8], thereby suggest-
ing that a sub-segmentation of these structures may contribute to more refined analyses of
structure-function relationships.
Interestingly, despite a 32% ventricular volume enlargement and a relationship between
DDD of antipsychotics and the lateral ventricles in the EOS group, which suggest that medica-
tion confounds structure-function relationships, there were equal relationships for the process-
ing speed, attention and reasoning and problem solving domains for the EOS and the HC
groups, i.e. larger ventricular volumes related to better neurocognitive functioning. A review of
brain structure and cognition in schizophrenia has also concluded that the relationship
between ventricular size and cognitive function is complex [11]. While an enlargement of the
ventricles has been found to be related to reduced motor speed in one study of adult onset
schizophrenia [10], the opposite finding has also been reported, with larger ventricular size was
associated with a higher IQ and better cognitive functioning [70].
In a previous publication, we argued that a positive correlation between antipsychotic medi-
cation dosage and ventricular volume could be attributed to more severe underlying brain
abnormalities and a more serious case of disease reflected in larger cerebral ventricles [22]. The
argument is supported by the finding of a significant relationship between the GAF symptom
score and the lateral ventricular volume. However, with regard to the present findings of better
neurocognitive functioning in patients with larger ventricular volumes, this argument seems
weakened, unless better neurocognitive functioning is related to more antipsychotic
medication.
In the hitherto longest follow-up study of adult schizophrenia, Andreasen et al. found anti-
psychotic treatment intensity to be related to brain volume changes, and suggested that clini-
cians should strive to use the lowest possible dosage to control symptoms [45]. In this context,
it is of clinical interest that in the present cross-sectional study, we find that enlarged lateral
ventricles showed a similar association to processing speed, attention and reasoning and prob-
lem solving for both patients and controls. These findings could indicate that neurocognition
and brain structure development follow separate trajectories [28, 71–73]. The enlarged cau-
date-reduced verbal learning relationship may suggest that antipsychotic medication affect
some aspect of the verbal learning neurocognitive process. With regard to relationship between
antipsychotic medication and neurocognitive function (including verbal learning), studies
report different effects with different neuroleptic agents, and the findings are inconsistent [74].
More generally, most studies have been statistically underpowered to detect moderate effect
sizes [60]. Another challenge is that most studies have been on stable chronic patients. Upcom-
ing future studies on patients in the early stages of illness, will possibly elucidate which subjects
are most likely to show an effect in neurocognitive function [60]. As the level of neurocognitive
impairment best predicts functional outcome in schizophrenia, potential detrimental effects on
neurocognitive function are of clinical relevance [75].
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Strengths and limitations
To our knowledge, this is the first study to investigate the subcortical brain structure-neurocog-
nitive function relationships in EOS. The methods and assessment tools used are well validated
and recommended for schizophrenia research [76]. The main limitation of the study is the low
number of subjects in both groups, and type 2 errors cannot be excluded. Furthermore, since
this was a naturalistic history study, we did not have adequate control over antipsychotic medi-
cation effects. Relationships between brain structure and neurocognitive function should be
investigated both prior to- and after the administration of antipsychotic medication. More
studies investigating the relationship between brain structures, antipsychotic- and neurocogni-
tive functioning are needed in EOS.
Conclusion
For the EOS patients, enlarged caudate volume was related to poorer performance on the ver-
bal learning domain. Interestingly, the associations between the lateral ventricles and process-
ing speed, attention and reasoning and problem solving domains were similar in both EOS and
HC despite a 32% ventricular enlargement in the patient group.
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